Acute hyperkeratotic and desquamative reaction in a patient with Sézary syndrome treated with bexarotene.
Bagazgoitia
L
L
Pérez-Carmona
L
L
Ríos
L
L
Muñoz
E
E
Harto
A
A
Jaén
P
P
D016588:Anticarcinogenic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000077610:Bexarotene; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects / Q000473:pathology; D008875:Middle Aged; D012751:Sezary Syndrome / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013764:Tetrahydronaphthalenes / Q000009:adverse effects* / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene